We recognize that innovation is as likely to occur in Sydney as it is San Diego; as likely in New Zealand as New York. Yet the traditional venture capital fund has found it difficult to look outside its region. Our model is to develop internationally competitive technologies and migrate them into the world's largest markets. Our vision is unique, but the problems we address are universal. Our investment model seeks to bring together the best fit of technology, people and capital to maximize the value of an innovation, wherever it is found.

Investment in agricultural biotechnology and agritech in New Zealand and Australia is an area of prime interest to us. A close association with our sister fund, Finistere Ventures, a life science venture capital firm based in San Diego provides access to markets in the United States. Finistere welcomes interest from professional investors and entrepreneurs, seeking superior returns in our industries of focus.